Associations between the levels of estradiol-, progesterone-, and testosterone-sensitive mirnas and main clinicopathologic features of breast cancer

Tatiana Kalinina, Vladislav Kononchuk, Efim Alekseenok, Grigory Abdullin, Sergey Sidorov, Vladimir Ovchinnikov, Lyudmila Gulyaeva

Research output: Contribution to journalArticlepeer-review

Abstract

Despite the existing advances in the diagnosis and treatment of breast cancer (BC), the search for markers associated with the clinicopathological features of BC is still in demand. MiRNAs (miRs) have potential as markers, since a change in the miRNA expression profile accompanies the initiation and progression of malignant diseases. The receptors for estrogen, androgen, and progesterone (ER, AR, and PR) play an important role in breast carcinogenesis. Therefore, to search for miRNAs that may function as markers in BC, using bioinformatic analysis and the literature data, we selected 13 miRNAs whose promoter regions contain binding sites for ER or AR, or putative binding sites for ER, AR, and PR. We quantified their expression in MCF-7 cells treated with estradiol, progesterone, or testosterone. The levels of miRNAs sensitive to one or more of these hormones were quantified in BC samples (n = 196). We discovered that high expression levels of miR-190b in breast tumor tissue indicate a positive ER status, and miR-423 and miR-200b levels differ between patients with and without HER2 amplification. The miR-193b,-423,-190a,-324, and-200b levels were associated with tumor size or lymph node status in BC patients, but the presence of these associations depended on the status and expression level of ER, PR, HER2, and Ki-67. We also found that miR-21 expression depends on HER2 expression in ER-and/or PR-positive BC. The levels of miRNA were significantly different between HER2 0 and HER2 1+ tumors (p = 0.027), and between HER2 0 and HER2 2+, 3+ tumors (p = 0.005).

Original languageEnglish
Article number4
JournalJournal of Personalized Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2022

Keywords

  • Biomarker
  • Breast cancer
  • Hormone-dependent car-cinogenesis
  • Lymph node metastasis
  • MicroRNA

OECD FOS+WOS

  • 3.02 CLINICAL MEDICINE
  • 3 MEDICAL AND HEALTH SCIENCES

Fingerprint

Dive into the research topics of 'Associations between the levels of estradiol-, progesterone-, and testosterone-sensitive mirnas and main clinicopathologic features of breast cancer'. Together they form a unique fingerprint.

Cite this